These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 18804406

  • 1. Expression of osteopontin and its receptors in ameloblastomas.
    Wang YP, Liu BY.
    Oral Oncol; 2009 Jun; 45(6):538-42. PubMed ID: 18804406
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of osteopontin and CD44v6 expression in odontogenic cystic lesions by immunohistochemistry.
    Salehinejad J, Saghafi S, Sharifi N, Zare-Mahmoodabadi R, Saghravanian N, Ghazi N, Shakeri MT.
    Pathol Res Pract; 2012 Jul 15; 208(7):410-4. PubMed ID: 22658130
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Podoplanin, E-cadherin, β-catenin, and CD44v6 in recurrent ameloblastoma: their distribution patterns and relevance.
    Siar CH, Ishak I, Ng KH.
    J Oral Pathol Med; 2015 Jan 15; 44(1):51-8. PubMed ID: 25059841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
    Sun BS, Li Y, Zhang ZF, You J, Wang CL.
    Ann Thorac Surg; 2013 Dec 15; 96(6):1943-51. PubMed ID: 24094519
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters.
    Scheper MA, Duarte EC, Intapa C, Zhang M, Nascimento LM, Almeida TP, Gomes AC, Song S, Chaisuparat R, Batista AC, Jham BC.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct 15; 114(4):497-502. PubMed ID: 22986245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.
    Ida-Yonemochi H, Ahsan MS, Saku T.
    Histopathology; 2011 Jan 15; 58(2):234-45. PubMed ID: 21255062
    [Abstract] [Full Text] [Related]

  • 14. [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma].
    Jiang LJ, Shao CK, He D, Li WG, Wu XZ, Cai DZ.
    Ai Zheng; 2008 Dec 15; 27(12):1263-6. PubMed ID: 19079990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
    Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J.
    J Cell Physiol; 2004 Jan 15; 198(1):155-67. PubMed ID: 14584055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
    Marroquin CE, Downey L, Guo H, Kuo PC.
    Immunol Lett; 2004 Aug 15; 95(1):109-12. PubMed ID: 15325806
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.